Abstract
GPR56, a non-classical adhesion receptor, was previously reported to suppress tumor growth and metastasis in xenograft models using human melanoma cell lines. To understand whether GPR56 plays similar roles in the development of endogenous tumors, we analyzed cancer progression in Gpr56 −/− mice using a variety of transgenic cancer models. Our results showed that GPR56 suppressed prostate cancer progression in the TRAMP model on a mixed genetic background, similar to its roles in progression of melanoma xenografts. However, its roles in other cancer types appeared to be complex. It had marginal effects on tumor onset of mammary tumors in the MMTV–PyMT model, but had no effects on subsequent tumor progression in either the MMTV–PyMT mice or the melanoma model, Ink4a/Arf −/− tyr-Hras. These results indicate diverse roles of GPR56 in cancer progression and provide the first genetic evidence for the involvement of an adhesion GPCR in endogenous cancer development.
Similar content being viewed by others
Abbreviations
- BFPP:
-
Bilateral frontoparietal polymicrogyria
- ECM:
-
Extracellular matrix
- GPCR:
-
G protein-coupled receptor
- GPR56:
-
G protein-coupled receptor 56
- MMTV:
-
Mouse mammary tumor virus
- PyMT:
-
Polyoma middle T oncogene
- RIPA:
-
Radio-immunoprecipitation assay
- TG2:
-
Tissue transglutaminase
- TRAMP:
-
Transgenic adenocarcinoma of the mouse prostate
References
Morgan MR, Humphries MJ, Bass MD (2007) Synergistic control of cell adhesion by integrins and syndecans. Nat Rev Mol Cell Biol 8(12):957–969
Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110(6):673–687
Miranti CK, Brugge JS (2002) Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4(4):E83–E90
Streuli CH, Akhtar N (2009) Signal co-operation between integrins and other receptor systems. Biochem J 418(3):491–506
Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7(4):339–357
Stacey M, Chang GW, Davies JQ et al (2003) The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 102(8):2916–2924
Kwakkenbos MJ, Pouwels W, Matmati M et al (2005) Expression of the largest CD97 and EMR2 isoforms on leukocytes facilitates a specific interaction with chondroitin sulfate on B cells. J Leukoc Biol 77(1):112–119
Xu L, Begum S, Hearn JD et al (2006) GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 103(24):9023–9028
Wang T, Ward Y, Tian L et al (2005) CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Blood 105(7):2836–2844
Vallon M, Essler M (2006) Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. J Biol Chem 281(45):34179–34188
Lorand L, Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4(2):140–156
Xu L, Hynes RO (2007) GPR56 and TG2: possible roles in suppression of tumor growth by the microenvironment. Cell Cycle 6(2):160–165
Li S, Jin Z, Koirala S et al (2008) GPR56 regulates pial basement membrane integrity and cortical lamination. J Neurosci 28(22):5817–5826
Koirala S, Jin Z, Piao X et al (2009) GPR56-regulated granule cell adhesion is essential for rostral cerebellar development. J Neurosci 29(23):7439–7449
Zendman AJ, Cornelissen IM, Weidle UH et al (1999) TM7XN1, a novel human EGF-TM7-like cDNA, detected with mRNA differential display using human melanoma cell lines with different metastatic potential. FEBS Lett 446(2–3):292–298
Shashidhar S, Lorente G, Nagavarapu U et al (2005) GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 24(10):1673–1682
Sud N, Sharma R, Ray R et al (2006) Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett 233(2):265–270
Frese KK, Tuveson DA (2007) Maximizing mouse cancer models. Nat Rev Cancer 7(9):645–658
Greenberg NM, DeMayo F, Finegold MJ et al (1995) Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92(8):3439–3443
Lin EY, Jones JG, Li P et al (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 163(5):2113–2126
Chin L, Pomerantz J, Polsky D et al (1997) Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev 11(21):2822–2834
Kaplan-Lefko PJ, Chen TM, Ittmann MM et al (2003) Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55(3):219–237
Wong SY, Haack H, Kissil JL et al (2007) Protein 4.1B suppresses prostate cancer progression and metastasis. Proc Natl Acad Sci USA 104(31):12784–12789
Gingrich JR, Barrios RJ, Morton RA et al (1996) Metastatic prostate cancer in a transgenic mouse. Cancer Res 56(18):4096–4102
Hurwitz AA, Foster BA, Allison JP, et al (2001) The TRAMP mouse as a model for prostate cancer. Curr Protoc Immunol, Chap. 20: Unit 20 5
Sharpless E, Chin L (2003) The INK4a/ARF locus and melanoma. Oncogene 22(20):3092–3098
Galle J, Aust G, Schaller G et al (2006) Individual cell-based models of the spatial-temporal organization of multicellular systems–achievements and limitations. Cytometry A 69(7):704–710
Nishimori H, Shiratsuchi T, Urano T et al (1997) A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15(18):2145–2150
Terskikh AV, Easterday MC, Li L et al (2001) From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci USA 98(14):7934–7939
Terskikh AV, Miyamoto T, Chang C et al (2003) Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102(1):94–101
Akimov SS, Krylov D, Fleischman LF et al (2000) Tissue transglutaminase is an integrin-binding adhesion coreceptor for fibronectin. J Cell Biol 148(4):825–838
Akimov SS, Belkin AM (2001) Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin. Blood 98(5):1567–1576
Iguchi T, Sakata K, Yoshizaki K et al (2008) Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a G alpha 12/13 and Rho pathway. J Biol Chem 283(21):14469–14478
Hall A (2009) The cytoskeleton and cancer. Cancer Metastasis Rev 28(1–2):5–14
Acknowledgments
We thank Dr. Rulang Jiang and Dr. Sunny Wong for critical reading of the manuscript. We also thank Dr. Sunny Wong for sharing protein lysates from the prostate cancer cell lines. This work was supported by grants from the NIH (U54CA126515, R.O.H), the Virginia and Daniel K Ludwig Fund for Cancer Research (R.O.H), and the Howard Hughes Medical Institute (R.O.H).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, L., Begum, S., Barry, M. et al. GPR56 Plays varying roles in endogenous cancer progression. Clin Exp Metastasis 27, 241–249 (2010). https://doi.org/10.1007/s10585-010-9322-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10585-010-9322-3